U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. ANTICOAGULANT SODIUM CITRATE 4% W/V SOLUTION USP - BA 125750
  1. Vaccines, Blood & Biologics

ANTICOAGULANT SODIUM CITRATE 4% W/V SOLUTION USP - BA 125750

STN: BA 125750
Proper Name: ANTICOAGULANT SODIUM CITRATE 4% W/V SOLUTION USP
Trade Name: N/A
Manufacture: CSL Plasma, Inc.
Indication:

  • ANTICOAGULANT SODIUM CITRATE 4% W/V SOLUTION USP is intended for use only for the anticoagulation of whole blood as part of automated apheresis procedures.

Product Information

Supporting Documents

Back to Top